ATE556051T1 - Neues heteroarylderivat - Google Patents

Neues heteroarylderivat

Info

Publication number
ATE556051T1
ATE556051T1 AT04747746T AT04747746T ATE556051T1 AT E556051 T1 ATE556051 T1 AT E556051T1 AT 04747746 T AT04747746 T AT 04747746T AT 04747746 T AT04747746 T AT 04747746T AT E556051 T1 ATE556051 T1 AT E556051T1
Authority
AT
Austria
Prior art keywords
optionally substituted
heteroaryl derivative
heteroaryl
single bond
new heteroaryl
Prior art date
Application number
AT04747746T
Other languages
English (en)
Inventor
Ken-Ichi Watanabe
Katsunori Maruta
Kantaro Ushiroda
Ryu Nagata
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE556051T1 publication Critical patent/ATE556051T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
AT04747746T 2003-07-15 2004-07-13 Neues heteroarylderivat ATE556051T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003274684 2003-07-15
PCT/JP2004/010282 WO2005012245A1 (ja) 2003-07-15 2004-07-13 新規ヘテロアリール誘導体

Publications (1)

Publication Number Publication Date
ATE556051T1 true ATE556051T1 (de) 2012-05-15

Family

ID=34113749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04747746T ATE556051T1 (de) 2003-07-15 2004-07-13 Neues heteroarylderivat

Country Status (12)

Country Link
US (2) US7425642B2 (de)
EP (1) EP1647546B1 (de)
JP (2) JP4820169B2 (de)
KR (1) KR101086654B1 (de)
CN (1) CN100516041C (de)
AT (1) ATE556051T1 (de)
CA (1) CA2531064C (de)
ES (1) ES2383895T3 (de)
HK (1) HK1087409A1 (de)
MX (1) MXPA06000539A (de)
TW (1) TW200523249A (de)
WO (1) WO2005012245A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006075638A1 (ja) * 2005-01-14 2008-06-12 大日本住友製薬株式会社 新規ヘテロアリール誘導体
US20060241073A1 (en) * 2005-04-20 2006-10-26 Wanders Ronaldus J A Means and methods for counteracting fatty acid accumulation
WO2008029825A1 (fr) 2006-09-05 2008-03-13 Kyowa Hakko Kirin Co., Ltd. Dérivé d'imidazole
WO2008157537A2 (en) * 2007-06-19 2008-12-24 Ironwood Pharmaceuticals, Inc Compositions and methods of use for treating or preventing lipid related disorders
CA2740058A1 (en) * 2008-10-31 2010-05-06 Dainippon Sumitomo Pharma Co., Ltd. An antidiabetic agent
US20120010264A1 (en) * 2009-03-26 2012-01-12 Dainippon Sumitomo Pharma Co., Ltd. Novel medicament for treating cognitive impairment
WO2011002012A1 (ja) * 2009-07-01 2011-01-06 大日本住友製薬株式会社 Sglt1阻害薬とインスリン抵抗性改善薬を組み合わせてなる医薬
KR20120117905A (ko) 2010-01-28 2012-10-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 프로테아좀 활성을 향상시키는 조성물 및 방법
JP5996532B2 (ja) 2010-07-15 2016-09-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 有害生物防除剤としての新規複素環式化合物
CN103635230B (zh) 2011-05-12 2017-10-31 普罗蒂斯特斯治疗公司 蛋白内稳态调节剂
WO2013138600A1 (en) * 2012-03-16 2013-09-19 Rosen Eliot M Radioprotector compounds
WO2014116228A1 (en) 2013-01-25 2014-07-31 President And Fellows Of Harvard College Usp14 inhibitors for treating or preventing viral infections
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752361A1 (de) * 1977-11-24 1979-06-07 Troponwerke Gmbh & Co Kg Neue indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO1998040385A1 (en) 1997-03-07 1998-09-17 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
EP1284260A4 (de) 2000-05-22 2004-03-31 Takeda Chemical Industries Ltd Tyrosin-phosphatase inhibitoren
JP2002121186A (ja) 2000-05-22 2002-04-23 Takeda Chem Ind Ltd チロシンホスファターゼ阻害剤
PT1294724E (pt) 2000-06-26 2006-07-31 Pfizer Prod Inc Compostos pirrolo (2,3-d ) pirimidina como agentes imunosupressivos
ES2309161T3 (es) * 2001-04-19 2008-12-16 Dainippon Sumitomo Pharma Co., Ltd. Derivados de pirrol.
JP2003171275A (ja) 2001-12-11 2003-06-17 Sumitomo Pharmaceut Co Ltd PPARδアゴニスト
WO2004048341A1 (ja) * 2002-11-28 2004-06-10 Sumitomo Pharmaceuticals Co., Ltd. 新規ヘテロアリール誘導体

Also Published As

Publication number Publication date
MXPA06000539A (es) 2006-03-30
JPWO2005012245A1 (ja) 2006-09-14
EP1647546B1 (de) 2012-05-02
CA2531064C (en) 2012-05-22
JP2011251974A (ja) 2011-12-15
TW200523249A (en) 2005-07-16
CA2531064A1 (en) 2005-02-10
KR20060040681A (ko) 2006-05-10
CN100516041C (zh) 2009-07-22
WO2005012245A1 (ja) 2005-02-10
US7425642B2 (en) 2008-09-16
HK1087409A1 (en) 2006-10-13
KR101086654B1 (ko) 2011-11-24
EP1647546A4 (de) 2008-07-23
US20060194857A1 (en) 2006-08-31
ES2383895T3 (es) 2012-06-27
JP4820169B2 (ja) 2011-11-24
TWI331142B (de) 2010-10-01
US20080306275A1 (en) 2008-12-11
CN1849303A (zh) 2006-10-18
EP1647546A1 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
HK1087409A1 (en) Novel heteroaryl derivative
TW200510441A (en) Novel compounds
CY1105797T1 (el) Ν-αρυλ-2-οχαζολιδινονο-5-καρβοξαμιδια και παραγωγα αυτων και χρηση αυτων σαν αντιβιοτικα
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
EP1736467A4 (de) Neues sulfonsäureamidderivat
WO2008108386A1 (ja) 医薬組成物
LU92113I2 (fr) Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA)
EP1541570A4 (de) Neue physiologisch wirksame substanz
DK1682138T3 (da) Heterocykliske inhibitorer af MEK
WO2006008250A3 (en) Oxime derivatives and the use therof as latent acids
EA200600348A1 (ru) Новые соединения
EA200700997A1 (ru) 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ
NO20063662L (no) Benzimidazolderivater
EP1837329A4 (de) Neues heteroarylderivat
NO20052907D0 (no) Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
CY1105734T1 (el) Nεα προ-φαρμακα του 1-μεθυλο-2-(4-αμιδινοφαινυλαμινομεθυλο)-βενζιμιδαζολ-5-υλιο-καρβοξυλικο οξυ-(ν-2-πυριδυλο-ν-2-υδροξυκαρβονυλαιθυλο)-αμιδιου, η παρασκευη και η χρησιμοποιηση τους ως φαρμακων
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
DE60044342D1 (de) Aminderivate
NO20051282L (no) Antitumorale analoger av lamellariner.
WO2005077926A3 (en) Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
ATE539124T1 (de) Härtbare zusammensetzung, farbfilter vom negativtyp und dessen herstellungsverfahren
ATE538118T1 (de) Pyrimidinylisoxazolderivat
EA200600551A1 (ru) Соединения пиперазина, способ их получения и фармацевтические композиции, которые их содержат